NCT07927452
Anatomic Versus Nonanatomic Liver Resection After Conversion Therapy for Hepatocellular Carcinoma
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Study First Submitted
Endpoints
Primary
2-year recurrence-free survival (RFS) rate
Timeframe: From enrollment to the end of treatment at 2 years
Secondary (3)
Recurrence-free survival (RFS)
Overall survival (OS)
Time to recurrence (TTR)
Arms and interventions
Anatomic Liver Resection (ALR)
Participants with HCC who undergo anatomic liver resection after conversion therapy.
Non-anatomic Liver Resection (NALR)
Participants with HCC who undergo nonanatomic liver resection after conversion therapy
Sites
1 site in 1 country
- Sun Yat-sen University Cancer CenterGuangzhou, Guangdong, China